Table 2.
Purpose for Using CAFG during Surgery and Incidence for Wound-related Reoperation within 90 Days following Primary Spine Surgery.
| Purpose for using CAFG | Number of
patients |
Incidence of reoperation
(cause for reoperation) |
(%) |
|---|---|---|---|
| Fixation of bone graft | 110 | 3
(deep SSI: 2) (superficial SSI: 1) |
(2.7) |
| Sealant for dural incision | 10 | 0 | (0) |
| Sealant for incidental durotomy | 7 | 1
(epidural hematoma: 1) |
(14.3) |
| Hemostatic agent | 4 | 0 | (0) |
CAFG, completely autologous fibrin glue; SSI, surgical site infection